Adipose Derived Mesenchymal Stem Cells for Kidney Failure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Mayo Clinic in Florida, Jacksonville, FLKidney FailureAdipose Derived Mesenchymal Stem Cells - Drug
Eligibility
18 - 85
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether it is safe to use a person's own stem cells to improve access for hemodialysis and whether it is effective.

Eligible Conditions
  • Kidney Failure

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12 months

12 months
Number of participants with treatment-related adverse events

Trial Safety

Trial Design

1 Treatment Group

Adipose Derived Mesenchymal Stem Cells
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Adipose Derived Mesenchymal Stem Cells · No Placebo Group · Phase 1

Adipose Derived Mesenchymal Stem Cells
Drug
Experimental Group · 1 Intervention: Adipose Derived Mesenchymal Stem Cells · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Albert HakaimLead Sponsor
Albert Hakaim, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital Jacksonville
Ohio State University College Of Medicine (Medical School)
Cleveland Clinic Fndn (Residency)
1 Previous Clinical Trials
2,700 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are expected to live for at least 2 years.

Frequently Asked Questions

Is it possible for me to be a participant in this research endeavor?

"This clinical trial calls for 15 renal failure patients aged 18-85 to meet the following criteria: adequate lifespans of at least 24 months, a preplanned upper extremity arteriovenous fistula, and postmenopausal/nonreproductive capability that is either reflected in medical records or verified with an official pregnancy test." - Anonymous Online Contributor

Unverified Answer

Does this medical experiment include younger participants under the age of eighteen?

"The enrollment guidelines for this clinical study stipulate that the youngest participants must be at least 18 years of age, with a maximum age limit of 85." - Anonymous Online Contributor

Unverified Answer

What risks, if any, are associated with using Adipose Derived Mesenchymal Stem Cells in patients?

"Limited data regarding the safety and efficacy of Adipose Derived Mesenchymal Stem Cells resulted in a score of 1." - Anonymous Online Contributor

Unverified Answer

Is there still availability for potential participants in this trial?

"Affirmative. Per the information available on clinicaltrials.gov, this health experiment is currently recruiting sufferers for participation; it was initially advertised on May 15th 2020 and last amended July 27th 2022. The trial seeks to enroll a total of fifteen participants across one medical centre." - Anonymous Online Contributor

Unverified Answer

What is the maximum capacity of participants for this research study?

"Affirmative. The clinicaltrials.gov site confirms that this trial, first uploaded on May 15th 2020, is currently searching for participants. Specifically, they hope to enlist 15 individuals from one medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.